The anticarcinogenic effect of rosemary has been partly attributed to the modulation of the activity and expression of phase II detoxification enzymes. Here we compared the effects of phenolic diterpenes from rosemary on the expression of NAD(P)H: quinone oxidoreductase 1 (NQO1) in rat Clone 9 liver cells. Cells were treated with 1-20 mmol/L of carnosic acid (CA) or carnosol (CS) for 24 h. Both CA and CS dose dependently increased NQO1 enzyme activity and protein expression, and the induction potency of CA was stronger than that of CS. The increase in NQO1 enzyme activity in cells treated with 10 mmol/L CA and CS was 4.1-and 1.9-fold, respectively (P , 0.05). RT-PCR showed that CA and CS induced NQO1 mRNA in a dose-dependent manner. Furthermore, CA dose dependently induced transcription of nuclear factor erythroid-2 related factor 2 (Nrf2) and antioxidant response element (ARE)-luciferase reporter activity. Silencing of Nrf2 expression alleviated NQO1 protein expression and ARE-luciferase activity by CA. Moreover, the phosphorylation of p38 was mainly stimulated in the presence of CA. Pretreatment with SB203580 or silencing of p38 expression inhibited Nrf2 activation and NQO1 induction. These results suggest that the increased NQO1 expression by CA is likely related to the p38-Nrf2 pathway and help to clarify the possible molecular mechanism of action of rosemary phenolic compounds in drug metabolism and cancer prevention. J. Nutr.
Introduction
Chemoprevention involves the use of dietary or pharmaceutical agents to reduce the risk of developing cancer. Phase I and phase II biotransformation enzymes are involved in the metabolic activation and detoxification of various classes of environmental carcinogens. Phase I enzymes, mainly cytochrome P450, detoxify a variety of endogenous and exogenous chemicals and activate many carcinogens (1) . Phase II enzyme systems, which include NQO1 4 , GST, and heme oxygenase-1, catalyze conjugation by sulfation or glucuronidation and neutralize electrophilic xenobiotics to facilitate their excretion (2) (3) (4) .
NQO1 is an FAD-dependent flavoprotein that protects cells against deleterious reactive semiquinones by converting exogenous quinones into hydroquinones via the 2-electron reduction mechanism (4) . The accumulated evidence supports that the elevation of this enzyme protects animals against a variety of chemical carcinogens (5) . Induction of NQO1 may play an important role in preventing azoxymethane-induced colon cancer in rats at the postinitiation stage (6) . The importance of NQO1 in cancer prevention is further supported by the fact that benzo[a]pyreneinduced skin cancer is significantly increased in NQO1-null mice (7) . Moreover, NQO1 has been proposed to stabilize the tumor suppressor gene p53 by blocking proteosomal degradation (8) .
Many studies have shown that the level of NQO1 gene expression is regulated mainly by a cis-acting enhancer sequence known as the ARE (4, 9) . Nrf2 is a basic leucine zipper transcriptional factor that plays a key role in ARE-mediated gene expression. Under basal conditions, Nrf2 is retained in the cytoplasm by the repressor protein Keap1 (10) . Oxidative stresses or chemical inducers inhibit the Nrf2-Keap1 interaction. Nrf2 then translocates into the nucleus and activates NQO1 or AREdependent phase II genes (4, 11) . Nrf2-deficient mice show decreased NQO1 gene expression that has also been reported to be associated with increased sensitivity to benzo[a]pyrene-induced gastric neoplasia (12) . The signaling pathways involved in Nrf2 activation are not fully clear. The MAPK pathway, including the ERK, JNK, and p38 kinase pathways, is known to be a common signal mediating Nrf2 activity (13) .
Rosemary (Rosmarinus officinalis) is commonly used as an herb, flavoring agent, and antioxidant in foods. The antioxidant properties of extracts of rosemary leaves are due to their content of phenolic diterpenes such as CS and CA (14) . Several studies have shown that rosemary phenolic diterpenes cause increases in the activities of phase II detoxifying enzymes such as GST, NQO1, and UDP-glucuronosyltransferases (15) (16) (17) . The application of rosemary extracts was shown to prevent DNA damage and tumor formation by 7,12-dimethylbenz[a]anthracene in mouse skin and rat mammary gland (18, 19) . The accumulated evidence supports that rosemary extracts inhibit benzo[a]pyreneinduced genotoxicity in human bronchial epithelial cells and that CA and CS are responsible for this effect (20) . Moreover, CA decreased 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis, most likely by inhibiting lipid peroxidation and modulating the effect of detoxification enzymes on carcinogens (21) . The results of these studies suggest that phenolic diterpenes from rosemary may inhibit carcinogenesis by stimulating the activity of NQO1. An understanding of the role of the phenolic diterpene-mediated signal pathway in NQO1 transcriptional regulation will help to clarify the possible molecular mechanism of action of rosemary in drug metabolism and cancer prevention.
Although the positive effects of phenolic diterpenes from rosemary on NQO1 are well characterized, the molecular mechanism of this upregulation is not yet clear. In this study, therefore, we first examined the efficacy of CA and CS on inducing NQO1 enzyme activity and protein expression in Clone 9 liver cells. Second, we determined the involvement of the MAPK-Nrf2 signaling pathway in NQO1 expression.
Materials and Methods
Chemicals. All chemicals were purchased from Sigma-Aldrich unless specified otherwise. RPMI-1640 medium, trypsin, and penicillinstreptomycin solution were obtained from Gibco Laboratory. Trizol was ordered from Invitrogen. FBS was purchased from Hyclone. RNase inhibitor, oligo dT, and MMLV reverse transcriptase were purchased from Promega. SB203580, PD98059, and SP600125 were purchased from TOCRIS.
Cell culture. Clone 9 cells, which were derived from normal rat livers, were purchased from Bioresources Collection and Research Center. They were grown in RPMI-1640 medium supplemented with 10 mmol/L HEPES, 1.5 g/L sodium bicarbonate, 1 3 10 5 unit/L penicillin, 100 mg/L streptomycin, and 10% FBS. Cells were incubated at 378C in a humidified atmosphere of 5% CO 2 and 95% air. For all studies, cells between passages 4 and 10 were used. Clone 9 cells were plated on 35-mm plastic tissue culture dishes (Falcon) at a density of 2.5 3 10 5 cells/dish and were allowed to grow for 24 h. Fresh medium containing 1, 5, 10, or 20 mmol/L of CA and CS was then added and the cells were incubated for 0.25, 0.5, 1, or 24 h. Inhibition of kinase activity by SB203580, PD98059, or SP600125 at a concentration of 20 mmol/L was initiated 1 h before CA treatment. Cells treated with 0.1% DMSO alone were regarded as controls.
Preparation of nuclear extracts. Cells were incubated with 10 mmol/L of CA for 0.5 h. Nuclear extract was performed according to our previous study (22) . The nuclear protein levels of Nrf-2 were determined by Western blotting. PARP was used as the loading control.
Western-blot analysis. Cell lysates were applied to 10% SDS-PAGE gels and were electrophoretically transferred to PVDF (Millipore). The nonspecific binding sites on the membranes were blocked at 48C overnight with 50 g/L nonfat dry milk and were then incubated with primary antibodies against NQO1, JNK1/2, ERK1/2, p38, phospho-JNK1/2, phospho-ERK1/2, phospho-p38, or Nrf2 (all from Santa Cruz Biotechnology), or PARP (Cell Signaling Technology) or b-actin (Sigma Chemical) overnight at 48C and were subsequently incubated with HRP-conjugated goat anti-rabbit IgG, goat anti-mouse IgG (all from Perkin Elmer Life Sciences), or rabbit anti-goat IgG (R&D Systems) as the secondary antibody. The bands were visualized by using an enhanced chemiluminescence kit (Perkin Elmer Life Science).
RT-PCR. Total RNA was extracted by using Trizol reagent. RT-PCR was performed as previously described (23) . The sequences for the RT-PCR primers were as follows: NQO1 (forward: 59-GCACGAATACGGTC-GATTC-39, reverse: 59-GTCGGCTGGAATGGACTTG-39); GAPDH (forward: 59-GACGTGCCGCCTGGAGAAA-39; reverse: 59-GGGGG-CCGAGTTGGGATAG-39). The PCR amplicons were then electrophoresed in 1%-agarose gels.
Enzyme activity assays. NQO1 activity was measured with 2,6-dichloroindophenol as the substrate. Briefly, the reaction mixture in a final volume of 1 mL contained 25 mmol/L Tris-HCl buffer (pH, 7.4), 20 mmol/L NADH, 0.4 mmol/L 2,6-dichloroindophenol, and an appropriate amount of the total proteins. The 2,6-dichloroindophenol reduced was measured at 600 nm (24) .
Transient transfection of small RNA interference. Clone 9 cells were plated on 35-mm plastic tissue culture dishes at a density of 2.5 310 5 cells/dish. When 80-90% confluence was reached, for p38 siRNA or Nrf2 siRNA transfection, the cells were transfected with p38 siRNA or Nrf2 siRNA (20 nmol/L) or nontargeting control siRNA by using the DharmaFECT siRNA transfection reagent according to the manufacturer's instruction (all from Thermo Fisher Scientific) for 24 h. The sense sequences of these p38-siRNA were as follows: 1) 59-GGACCUC-CUUAUAGACGAA-39; 2) 59-GCACACUGAUGACGAAAUG-39; 3) 59-ACACUCGGCUGACAUAAUC-39; and 4) 59-GAAUGUGAUUG-GUCUGUUG-39. The sense sequences of these Nrf2 siRNA were as follows: 1) 59-GAACACAGAUUUCGGUGAU -39; 2) 59-AGACAAA-CAUUCAAGCCGA -39; 3) 59-GGGUUCAGUGACUCGGAAA -39; and 4) 59-AGAAUAAAGUUGCCGCUCA -39. The cells were then changed to fresh culture medium containing 10 mmol/L CA for 0.5 or 24 h and protein expression was examined by Western-blot analysis. For luciferase assay, cells were transfected with p2xARE/Luc vectors before CA treatment.
Plasmids, transfection, and luciferase assays. A p2xARE/Luc fragment containing tandem repeats of double-stranded oligonucleotides spanning the Nrf2 binding site, 59-TGACTCAGCA-39, as previously described by Kataoka et al. (25) , was introduced into the pGL3 promoter plasmid (Promega). Cells were transiently transfected for 5 h with 0.1 mg of the p2xARE/Luc vectors by nanofectin reagent and were then exposed to CA for an additional 20 h. The luciferase assay was performed according to our previous study (22) .
Statistical analysis. Statistical analysis was performed with commercially available software (SAS Institute). For each diterpene, the effects of concentration or time were tested by 1-way ANOVA and Tukey's test. Two-way ANOVA was used to test the effects of diterpene and concentration and their interaction. Differences between two means were assessed using Student's t test. Differences were considered significant at P , 0.05.
Results
Effect of phenolic diterpenes from rosemary on NQO1 enzyme activity. In the studies reported here, cells were incubated with 1-20 mmol/L of CA or CS for 24 h. To ensure that no cytotoxicity resulted by treatment with the two phenolic diterpenes from rosemary, we first performed a cell viability assay. The 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide method (Supplemental Methods) showed that each of the phenolic compounds tested at the concentrations stated above resulted in cell viability .95%. We then used 2,6-dichlorphenolindophenol as a substrate to measure NQO1 enzyme activity. We found that CA and CS dose dependently increased NQO1 enzyme activity in Clone 9 cells and the increase in expression caused by CA was higher than that caused by CS (Fig. 1) .
Effect of phenolic diterpenes from rosemary on NQO1 protein and mRNA expression. By Western blot, the increases in NQO1 protein levels were consistent with the changes noted in enzyme activity (Fig. 2A) . CA and CS induced NQO1 protein expression in a dose-dependent manner. CA and CS at 10 mmol/L caused 4.4-and a 2.9-fold increases, respectively, in the NQO1 protein level compared with that in the control cells (P , 0.05). The increase in expression caused by CA was higher than that caused by CS. In addition, there was a dose-dependent induction of NQO1 mRNA in cells treated with CA or CS (Fig. 2B) .
Effect of Nrf2 on NQO1 gene expression induced by CA. Most of the genes encoding phase II detoxifying and antioxidant enzymes contain an ARE sequence in their promoter region. Nrf2 has been reported to interact with the ARE (26) . We next studied whether the NQO1 expression upregulated by CA was associated with Nrf2 expression in Clone 9 cells. The immunoblotting results indicated that CA dose dependently increased Nrf-2 nuclear protein (Fig. 3A) . Moreover, after transient transfection of 23 ARE reporter into Clone 9 cells, CA increased the luciferase activity in a dose-dependent manner (P , 0.05) (Fig. 3B ). To further demonstrate the involvement of the transcription factor Nrf2 in the regulation of ARE reporter and NQO1 protein level, we used knockdown of Nrf2 by siRNA transfection. The luciferase activity was stimulated in the presence of CA. With Nrf2 siRNA, the luciferase activity was decreased (Fig. 3C) . The immunoblotting results indicated that the activation of Nrf2 and expression of NQO1 protein were inhibited in Nrf2 siRNAtransfected control cells (Fig. 3D) . CA treatment increased the activation of Nrf2 and induction of NQO1 protein in cells transfected with a nontargeting control siRNA. However, transfection of Nrf2 siRNA inhibited the CA-induced activation of Nrf2 and induction of NQO1 expression (Fig. 3D ).
CA and MAPK kinases. The MAPK signaling pathways, including JNK, ERK, and p38, are upstream mediators of Nrf2 (13) . The activation of individual MAPK kinases at different time points was determined. Immunoblot analysis showed that phosphorylation of p38 was increased by CA in a time-dependent manner (Fig. 4) . Maximal activation of ERK was observed after 15 min of stimulation. Moreover, ERK activation was more transient. By comparison, the extent of ERK activation was less than that noted for p38. No difference in JNK phosphorylation was detected during the time course.
CA activates NQO1 via the p38-Nrf2 pathway. To further explore whether the p38 pathway is involved in CA-mediated Nrf2 activation and NQO1 protein expression in Clone 9 cells, we used p38 inhibitor (SB203580) or knockdown of p38 by siRNA transfection. The immunoblot results showed that SB203580 suppressed the CA-induced NQO1 protein level (P , 0.05) (Fig.  5A) . Knockdown p38 by siRNA transfection was tested to determine the critical role of p38 in Nrf2 activation and, thus, NQO1 induction by CA. Immunoblots showed that p38 activation and NQO1 protein expression were inhibited in p38 siRNA-transfected control cells (Fig. 5B) . The activation of p38 and Nrf2 was stimulated in the presence of CA for 30 min. With p38 siRNA, the cellular p38 level was dramatically decreased (vs. si-control), which resulted in reducing the phosphorylation of p38 by CA. Activation of Nrf2 and induction of NQO1 expression by CA was correspondingly suppressed. In addition, we used PD98059 and SP600125 to explore whether the ERK and JNK pathways are involved in CA-mediated NQO1 protein expression. The results showed that activation of Nrf2 and induction of NQO1 expression were stimulated in the presence of CA (Fig. 5C) . Pretreatment with PD98059 and SP600125 had no effect. 
Discussion
Several studies have indicated that the phase II enzyme NQO1 catalyzes the metabolic detoxification of quinones and protects cells against chemical-induced oxidative stress and cancer (4, 5) . Induction of NQO1 protects neuronal cells against neurocytotoxicity caused by dopamine, 6-hydroxydopamine, or hydrogen peroxide (27, 28) . The importance of NQO1 in cancer prevention is supported by the finding that NQO1-null mice are more susceptible to DMBA-and benzo[a]pyrene-induced skin cancer (7, 29) . It is suggested that NQO1 controls the stabilization of tumor suppressor p63 or p53 protein and progression toward keratinocyte differentiation leading to normal skin development (7, 30) . Moreover, induction of NQO1 prevents estrogen quinone-induced formation of DNA adducts and mammary cancer (31, 32) . Because NQO1 can be induced by numerous dietary factors, it is accepted that enhancement of NQO1 expression and activity through a dietary regimen is a practical means of cancer chemoprevention. Dietary administration of polyphenols may exert chemopreventive effects in the lung, prostate, kidney, bladder, and liver by enhancing the NQO1 detoxification enzyme (33) (34) (35) . The results of the present study indicate that 2 phenolic diterpenes from rosemary, CA and CS, differentially upregulate NQO1 expression in Clone 9 cells. Moreover, we further showed that such upregulation by CA is likely p38-Nrf2 dependent.
The phenolic diterpenes from rosemary, like CA, CS, and rosmanol, have biological properties such as antiinflammatory, antioxidative, antiviral, and anticarcinogenic activities (36) (37) (38) (39) . Soler-Rivas et al. (40) indicated that supplementation of the rosemary extracts should include an oily matrix and lecithin as carrier to enhance their bioaccessibility. CA can be converted into CS by air oxidation. However, CS was not the metabolite of CA in rat plasma. The antioxidant activity of CA may be due to its derivatives and digestion products (41) . In the present study, CA and CS increased NQO1 protein and enzyme activity in Clone 9 cells, and the effects of the phenolic diterpenes were in the order CA . CS (Figs. 1 and 2A) . The results of accumulated studies indicate that CA is the most abundant antioxidant found in the leaves of rosemary (14, 42) . The catechol form of CA slowly oxidizes to the quinone derivative, an electrophilic compound, which serves as a target for nucleophilic attack by GSH or other protein thiols (43) . By this reaction, CA reacts with the cysteine thiol of Keap1 protein to form a Keap1-CA adduct and releases Nrf2 protein from the Keap1/Nrf2 complex. Nrf2 then translocates into the nucleus and activates transcription of phase II enzymes via ARE transcriptional elements (17) . Moreover, CA is much more potent at protecting mouse HT22 neuronal cells against oxidative glutamate toxicity than is CS and this could be FIGURE 3 CA increased Nrf2 activation (A,D) and ARE-luciferase activity (B,C) in Clone 9 cells. In A, the nuclear protein levels of Nrf-2 were determined by Western blotting. PARP was used as the loading control. In B, the level in control cells was set at 1.0. Values are means 6 SD, n = 3. Means without a common letter differ, P , 0.05. In C, cells were transfected with Nrf2 siRNA (si-Nrf2) or nontargeting control siRNA (si-control) for 24 h. The cells were then transfected with the ARE reporter plasmid. The luciferase activity in control cells was set at 1. Values are means 6 SD, n = 3. Means without a common letter differ, P , 0.05. In D, the activation of Nrf2 and expression of NQO1 protein were measured by Western blotting. ARE, antioxidant response element; CA, carnosic acid; Nrf2, nuclear factor erythroid-2 related factor 2; PARP, poly(ADP)-ribose polymerase; siRNA, small interfering RNA. attributed to the hydrophilic features of CA owing to its free carbonic acid and catechol hydroxyl moieties (44) .
Several genes encoding antioxidant enzymes and phase II detoxifying enzymes such as NQO1 and GST are regulated by the ARE (45, 46) . In the present study, CA increased the nuclear translocation of Nrf2 and induced ARE-luciferase activity (Fig. 3) , which suggests that CA may induce the expression of AREregulated genes. The transcription factor Nrf2 may dimerize with a small Maf protein and bind to the ARE, resulting in the transcriptional regulation of these enzymes (47) . The findings of a recent work by Chen et al. (48) support that CS induces Nrf2-mediated glutamate-cysteine ligase expression, which in turn controls GSH synthesis in human hepatoma HepG2 cells. Satoh et al. (44) also suggested that CA induces NQO1 mRNA through the activation of the ARE in neuronal HT22 cells. In another study, constitutive hepatic and gastric activities of NQO1 were reduced by 50-80% in Nrf2-deficient mice compared with wildtype mice (12) . In the present study, CA induced the expression of NQO1 through the Nrf2/ARE signaling pathway in Clone 9 cells.
Accumulating evidence suggests that the ERK, JNK, and p38 kinase pathways are associated with the Nrf2 pathway. Phosphorylation of Nrf2 by kinases such as ERK and JNK is assumed to facilitate the release of Nrf2 from Keap1 and subsequent translocation (49, 50) . The p38 kinase may either stimulate or inhibit Nrf2 nuclear translocation, depending on the cell type (3, 51) . In recent years, evidence has indicated that activation of the MAPK is closely associated with the biological effects of phenolic diterpenes from rosemary in different cell lines. Rosmanol potently inhibits LPS-induced NO synthase and COX-2 expression through downregulation of the MAPK signaling pathways in RAW 264.7 cells (52). Martin et al. (3) indicated that p38 kinase, but not the ERK and JNK pathways, is required for the upregulation of heme oxygenase-1 protein levels by CS in rat pheochromocytoma PC12 cells. CA and edaravone treatment synergistically enhances nerve growth factor expression through the JNK-dependent Nrf2 pathway in human astrocytes (53) . CA activates cholinergic activities in PC12 cells through phosphorylation of ERK1/2 (54). In SN4741 neuronal cells, CA attenuated dieldrin-induced cell death through inhibition of JNK pathway (55) . These effects are likely cell type specific. Moreover, CA protects neuronal cells and is involved with the induction of NQO1 expression and the activation of the Keap1/ Nrf2 pathway (43) . In the present study, we showed that p38 activation occurs before the induction of NQO1 by CA and that this upregulation and Nrf2 are suppressed by SB203580 and p38 siRNA (Fig. 5A,B) . However, the induction by CA had no effect in cell pretreatment with PD98059 and SP600125 (Fig. 5C ). This evidence indicates that the p38 signaling pathways are important in the upregulation of NQO1 by CA. In contrast, ERK and JNK are dispensable for NQO1 upregulation. To our knowledge, this is the first report showing that the induction of NQO1 activity by CA is dependent on the p38-Nrf2 signaling pathways.
In conclusion, CA and CS differentially upregulated the protein expression and enzyme activity of NQO1, and the induction potency of CA was stronger than that of CS. Moreover, the p38-Nrf2 signaling pathway is likely related to the induction of this phase II detoxification enzyme.
